Other languages Bavarian Nordic A/S

Equities

BAVA

DK0015998017

Market Closed - Nasdaq Copenhagen Other stock markets 08:29:35 26/04/2024 pm IST			5-day change	1st Jan Change
148.8 ^DKK	+3.26%		+1.02%	-16.12%

13/03	Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults	MT
13/03	Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OPINIONES DE LOS ANALISTAS DEL DÍA : Acciona, LVMH, Endesa, Viscofan, Easyjet, Repsol, Unibail, Sika, Rio Tinto, Unicredit, ASML...	18/04
Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults	13/03
Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland	13/03
Bavarian Nordic A/S Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Bavarian Nordic Receives Accelerated Assessment Status for Chikungunya Vaccine	23/02
Bavarian Nordic A/S Announces Accelerated Assessment for the Upcoming Marketing Authorisation Application for CHIKV VLP	23/02
ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial	21/02
Bavarian Nordic A/S Provides Revenue Guidance for the Year 2024	21/02
Stigma, regulatory barriers delay mpox response in country that needs it most	05/12
Les marchés rêvent d'un scénario ciel bleu	30/11
Bolsa de Madrid: Los mercados sueñan con un escenario de cielo azul	30/11
Bavarian Nordic Confirms FY23 Revenue Growth Outlook	16/11
Bavarian Nordic A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11
Bavarian Nordic A/S Provides Earnings Guidance for the Year 2023	16/11
Le Nasdaq en perd son Alphabet	26/23/26
AVIS D'ANALYSTES DU JOUR : Worldline, Kering, Dassault Systèmes, GTT, Nexity, Straumann...	26/23/26
Bavarian Nordic Wins US Regulatory Nod for Mpox Vaccine in Adults	26/23/26
US CDC panel recommends Bavarian Nordic's vaccine for adults at risk of mpox	25/23/25
Bavarian Nordic A/S's Mpox Vaccine Receives Recommendation from U.S. CDC Advisory Committee for Routine Use in Adults at Risk	25/23/25
ÜBERBLICK/Anstehende Indexänderungen	09/23/09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bavarian Nordic A/S

Equities

BAVA

DK0015998017

Other languages

Filters